openPR Logo

Press Releases from DelveInsight Business Research LLP (4751 total)

Inherited Retinal Disease Market: Epidemiology, Therapies, Companies, DelveInsig …

Inherited Retinal Disease therapies, such as LUXTURNA, GS030, EA-2353, ADX-2191, and others, are expected to boost the Inherited Retinal Disease Market in the upcoming years. DelveInsight

Cholestatic Pruritus Market Size in 7MM is expected to grow at a decent CAGR by …

DelveInsight's "Cholestatic Pruritus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as

Diffuse Cutaneous Systemic Sclerosis Market Size in 7MM is expected to grow at a …

DelveInsight's "Diffuse Cutaneous Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Diffuse Cutaneous Systemic Sclerosis, historical and forecasted

Liver Cancer Pipeline Appears Robust With 70+ Key Pharma Companies Actively Work …

DelveInsight's, "Liver Cancer Pipeline Insight 2025" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the

Hodgkin's Lymphoma Pipeline Appears Robust With 15+ Key Pharma Companies Activel …

DelveInsight's, "Hodgkin's Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Hodgkin's Lymphoma pipeline landscape. It covers the

Head and Neck Cancer Pipeline Appears Robust With 80+ Key Pharma Companies Activ …

DelveInsight's "Head and Neck Cancer Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Head and Neck cancer pipeline

Ataxia telangiectasia Pipeline 2025: Groundbreaking Clinical Advancements by 5+ …

With Ataxia telangiectasia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Cystinuria Pipeline 2025: Groundbreaking Clinical Advancements by 5+ Global Lead …

With Cystinuria reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand

Leber's hereditary optic neuropathy Pipeline 2025: Groundbreaking Clinical Advan …

With Leber's hereditary optic neuropathy reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is

Leber's hereditary optic neuropathy Pipeline 2025: Groundbreaking Clinical Advan …

With Leber's hereditary optic neuropathy reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is

Sanfilippo syndrome Pipeline 2025: Groundbreaking Clinical Advancements by 8+ Gl …

With Sanfilippo syndrome reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Down Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight | AC Immu …

Down Syndrome therapies, such as AEF0217, ACI-24.060, and others, are expected to boost the Down Syndrome Market in the upcoming years. DelveInsight has launched a new

Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …

Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the

Single Ventricle Heart Disease Market: Epidemiology, Therapies, Companies, Delve …

Single Ventricle Heart Disease emerging therapies, such as Udenafil, JRM-001, and others, are expected to boost the Single Ventricle Heart Disease Market in the upcoming

Periodontal Disease Market: Epidemiology, Therapies, Companies, DelveInsight | V …

Periodontal Disease therapies, such as VAX PG, AL102-PDT, COR-588, ST266, AMY-101, P4M01, and others, are expected to boost the Periodontal Disease Market in the upcoming

Treatment-Resistant Hypertension Market: Epidemiology, Therapies, Companies, Del …

Treatment-Resistant Hypertension therapies, such as Baxdrostat (CIN-107), Lorundrostat (MLS-101), TRYVIO/JERAYGO (aprocitentan), and others, are expected to boost the Treatment-Resistant Hypertension Market in the upcoming years. DelveInsight

Chronic periodontitis Pipeline 2025: Groundbreaking Clinical Advancements by 10+ …

With Chronic periodontitis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Huntington's Disease Pipeline 2025: Groundbreaking Clinical Advancements by 20+ …

With Huntington's Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Ultrasound Devices Market to Witness Upsurge in Growth by 2030, Assesses DelveIn …

DelveInsight's Ultrasound Devices Market Insights report provides the current and forecast market analysis, individual leading Ultrasound Devices Companies' market shares, challenges, Ultrasound Devices Market Drivers,

Coronary Stent Market to Witness Upsurge in Growth by 2030, Assesses DelveInsigh …

DelveInsight's Coronary Stent Market Insights report provides the current and forecast market analysis, individual leading Coronary Stent Companies' market shares, challenges, Coronary Stent Market Drivers,

Intranasal Drug Delivery Market to Witness Upsurge in Growth by 2030, Assesses D …

DelveInsight's Intranasal Drug Delivery Market Insights report provides the current and forecast market analysis, individual leading Intranasal Drug Delivery Companies market shares, challenges, Intranasal Drug

Diffuse Large B-cell Lymphoma Treatment Market Size in 7MM is expected to grow a …

DelveInsight's "Diffuse large B-cell lymphoma Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Diffuse Large B-Cell Lymphoma, historical and

Alzheimer's Disease Market Size in 7MM is expected to grow at a decent CAGR by 2 …

DelveInsight's "Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Alzheimer's disease, historical and forecasted epidemiology as

Acute Myeloid Leukemia Market Size in 7MM is expected to grow at a decent CAGR b …

DelveInsight's "Acute Myeloid Leukemia Treatment Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Acute Myeloid Leukemia, historical and forecasted

Ovarian Cancer Drugs Market Size in 7MM is expected to grow at a decent CAGR by …

DelveInsight's "Ovarian Cancer Market Insight, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of high- and low-grade serous ovarian cancer, its historical and forecasted

Traumatic Brain Injury Treatment Market Size in 7MM is expected to grow at a dec …

DelveInsight's "Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the TBI, historical and forecasted epidemiology and

Sepsis Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimate …

DelveInsight's "Sepsis Drugs Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Sepsis, historical and forecasted epidemiology as well as

Alport syndrome Pipeline 2025: Groundbreaking Clinical Advancements by 4+ Global …

With Alport syndrome reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Arteriovenous (AV) Fistula Pipeline 2025: Groundbreaking Clinical Advancements b …

With Arteriovenous (AV) Fistula reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a

Ischemia Reperfusion Injury Pipeline 2025: Groundbreaking Clinical Advancements …

With Ischemia Reperfusion Injury reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a

Juvenile Macular Degeneration Pipeline 2025: Groundbreaking Clinical Advancement …

With Juvenile Macular Degeneration reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a

Urea cycle disorders Pipeline 2025: Groundbreaking Clinical Advancements by 8+ G …

With Urea cycle disorders reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a

Spinal cord injury Pipeline 2025: Groundbreaking Clinical Advancements by 25+ Gl …

With Spinal cord injury reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a

Fabry Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Amicus …

Fabry Disease emerging therapies, such as Venglustat, Isaralgagene civaparvovec (ST-920), AMT-191, and others, are expected to boost the Fabry Disease Market in the upcoming years. DelveInsight

Acute Coronary Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight …

Acute Coronary Syndrome therapies, such as LODOCO (colchicine), TNKase (tenecteplase), REPATHA (evolocumab), ZONTIVITY (vorapaxar), PRALUENT (alirocumab), LOVENOX (enoxaparin sodium), Aggrastat (tirofiban), REOPRO (abciximab), and others,

Metachromatic Leukodystrophy Pipeline 2025: Groundbreaking Clinical Advancements …

With Metachromatic Leukodystrophy reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

GM1 Gangliosidosis Market: Epidemiology, Therapies, Companies, DelveInsight | Pa …

GM1 Gangliosidosis therapies, such as PBGM01, and others, are expected to boost the GM1 Gangliosidosis Market in the upcoming years. DelveInsight has launched a new report

Tay-Sachs Disease Pipeline 2025: Groundbreaking Clinical Advancements by 4+ Glob …

With Tay-Sachs Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Multiple Myeloma Pipeline 2025: Groundbreaking Clinical Advancements by 75+ Glob …

With Multiple Myeloma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Genital Herpes Pipeline 2025: Groundbreaking Clinical Advancements by 18+ Global …

With Genital Herpes reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Eczema Pipeline 2025: Groundbreaking Clinical Advancements by 100+ Global Leader …

With Eczema reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand

Porphyria Pipeline 2025: Groundbreaking Clinical Advancements by 10+ Global Lead …

With Porphyria reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand

Non-Invasive Prenatal Testing Market Set for Steady Expansion by 2032, Driven by …

Global non-invasive prenatal testing (NIPT) market was valued at USD 3,916 million in 2023 and is projected to grow at a compound annual growth rate

Vascular Closure Devices Market Set for Steady Expansion by 2032, Driven by Inno …

The vascular closure devices market was valued at USD 1.05 billion in 2023 and is projected to grow at a CAGR of 6.15%, reaching approximately

Injectable Drug Delivery Devices Market Set for Steady Expansion by 2032, Driven …

The injectable drug delivery devices market was valued at USD 19.63 billion in 2023 and is projected to grow at a compound annual growth rate

Orthopedic Prosthesis Devices Market Set for Steady Expansion by 2032, Driven by …

The orthopedic prosthesis devices market was valued at USD 2.11 billion in 2023 and is projected to reach approximately USD 2.96 billion by 2030, expanding

Buerger's disease Pipeline 2025: Groundbreaking Clinical Advancements by 3+ Glob …

With Buerger's disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing

Smoking cessation and nicotine addiction Market: Epidemiology, Therapies, Compan …

Smoking cessation and nicotine addiction emerging therapies, such as Cytisinicline (cytisine), NFL-101, EMB-001, and others, are expected to boost the Smoking cessation and nicotine addiction

Beta thalassemia Market: Epidemiology, Therapies, Companies, DelveInsight | Nova …

Beta thalassemia emerging therapies, such as Mitapivat (AG-348), and others, are expected to boost the Beta thalassemia Market in the upcoming years. DelveInsight has launched a

Warm autoimmune hemolytic anemia Market: Epidemiology, Therapies, Companies, Del …

Warm autoimmune hemolytic anemia emerging therapies, such as Obexelimab (ZB012), Nipocalimab (M281), and others, are expected to boost the Warm autoimmune hemolytic anemia Market in

Go To Page:    1 2 3 4 5 6 7 8 9 10 81 82 83 84 85 86 87 88 89 90